203 related articles for article (PubMed ID: 35799324)
1. Exploring electrophysiological markers of auditory predictive processes and pathological ageing in adults with Down's syndrome.
Avancini C; Jennings S; Chennu S; Noreika V; Le A; Bekinschtein TA; Walpert MJ; Clare ICH; Holland AJ; Zaman SH; Ring H
Eur J Neurosci; 2022 Nov; 56(9):5615-5636. PubMed ID: 35799324
[TBL] [Abstract][Full Text] [Related]
2. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials.
Blackwood DH; St Clair DM; Muir WJ; Oliver CJ; Dickens P
J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():439-53. PubMed ID: 2976841
[TBL] [Abstract][Full Text] [Related]
3. [The aging of Down's Syndrome subjects].
Fromage B; Anglade P
Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
[TBL] [Abstract][Full Text] [Related]
4. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
[TBL] [Abstract][Full Text] [Related]
5. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
6. Use of electroencephalography to detect Alzheimer's disease in Down's syndrome.
Visser FE; Kuilman M; Oosting J; Overweg J; van Wijk J; van Huffelen AC
Acta Neurol Scand; 1996 Aug; 94(2):97-103. PubMed ID: 8891053
[TBL] [Abstract][Full Text] [Related]
7. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
[TBL] [Abstract][Full Text] [Related]
8. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivity.
Wilson LR; Vatansever D; Annus T; Williams GB; Hong YT; Fryer TD; Nestor PJ; Holland AJ; Zaman SH
Hum Brain Mapp; 2019 Oct; 40(15):4551-4563. PubMed ID: 31350817
[TBL] [Abstract][Full Text] [Related]
10. Cognitive deficits and associated neurological complications in individuals with Down's syndrome.
Lott IT; Dierssen M
Lancet Neurol; 2010 Jun; 9(6):623-33. PubMed ID: 20494326
[TBL] [Abstract][Full Text] [Related]
11. A four year prospective study of age-related cognitive change in adults with Down's syndrome.
Oliver C; Crayton L; Holland A; Hall S; Bradbury J
Psychol Med; 1998 Nov; 28(6):1365-77. PubMed ID: 9854278
[TBL] [Abstract][Full Text] [Related]
12. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
13. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
14. Age-related cognitive decline and electroencephalogram slowing in Down's syndrome as a model of Alzheimer's disease.
Soininen H; Partanen J; Jousmäki V; Helkala EL; Vanhanen M; Majuri S; Kaski M; Hartikainen P; Riekkinen P
Neuroscience; 1993 Mar; 53(1):57-63. PubMed ID: 8469312
[TBL] [Abstract][Full Text] [Related]
15. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
[TBL] [Abstract][Full Text] [Related]
16. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
de la Monte SM; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
[TBL] [Abstract][Full Text] [Related]
17. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and Down's syndrome.
Mann DM
Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
[TBL] [Abstract][Full Text] [Related]
19. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
[TBL] [Abstract][Full Text] [Related]
20. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
